leadforensics

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies. Find out more about cookies.

Click here to dismiss this banner

PHARMA REPORT

rss_Pharma.jpg...see all
Global Neuromodulation Devices Report 2018-2028

Global Neuromodulation Devices Report 2018-2028

Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications

Product code: PHA0299

  • Publication date: 09/04/2018
  • Number of Pages: 221
  1. Report Details
  2. Table of Contents
  3. Companies Listed

Report Details

The neuromodulation devices market is estimated to grow at a CAGR of 11.7% in the first half of the forecast period. The Spinal Cord Stimulation (SCS) submarket is estimated to account for 43.6% share of this market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 221-page report you will receive 125 charts– all unavailable elsewhere.

The 221-page report provides clear detailed insight into the global neuromodulation devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Neuromodulation Devices market forecasts from 2018-2028

• This report also breaks down the revenue forecast for the global neuromodulation devices market by type:
• Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS)
• Vagus Nerve Stimulation (VNS)
• Sacral Nerve Stimulation (SNS)
• Gastric Electrical Stimulation (GES)
• Other Applications

This report discusses the market trends and lists the leading products/pipeline products of each submarket.

• This report provides individual revenue forecasts to 2028 for these regional and national markets:
• North America: the US and Canada
• Europe: France, Germany, Italy, U.K, Spain, Russia, Rest of Europe
• Asia-Pacific: Japan, China, India, Australia, South Korea and rest of Asia-Pacific
• Latin America: Brazil, Mexico, Rest of Latin America
• Rest of the World: Middle East, Africa

Global Neuromodulation Devices Report 2018-2028

Each regional market is further segmented by type of applications: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications

• Our study gives qualitative analysis of the neuromodulation devices market. It discusses the factors that drive and restrain the neuromodulation devices market. This study also provides a SWOT and STEP analysis.

• Our study discusses the selected leading companies that are the major players in the neuromodulation devices industry:
• Medtronic
• Boston Scientific
• St Jude Medical (Abbott)
• Cyberonics (LivaNova)
• Stryker Corporation
• Nevro Corp.
• SetPoint Medical
• Functional Neuromodulation
• Neurotherapies Reset
• Wringless Implantable Stretchable Electronics (WISE)
• SceneRay
• Mindray

Visiongain’s study is intended for anyone requiring commercial analyses for the global neuromodulation devices market. You find data, trends and predictions.

Buy our report today Global Neuromodulation Devices Report 2018-2028: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Table of Contents

1. Report Overview
1.1 Overview of the World Market for Neuromodulation Devices
1.2 Why You Should Read This Report
1.3 How this Report Delivers
1.4 Main Questions Answered by this Analysis
1.5 Who is this Report For?
1.6 Methodology
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain

2. Introduction to Neuromodulation
2.1 Neuromodulation
2.2 Techniques Used in Neuromodulation
2.2.1 Electrical Stimulation Techniques
2.2.2 Pharmacological Therapy
2.3 Application of Neuromodulation
2.3.1 Pain
2.3.2 Depression
2.3.3 Epilepsy
2.3.4 Faecal and Urinary Incontinence
2.3.5 Hearing Disorders – Profound Deafness
2.3.6 Cardiovascular Diseases – Arrhythmia and Angina

3. Global Neuromodulation Devices Market 2018-2028
3.1 Neuromodulation Devices Market: 2018
3.2 Neuromodulation Devices Market Forecast by Type: 2018-2028
3.3 Neuromodulation Devices Market Forecast by Region: 2018-2028
3.4 Neuromodulation Devices: Industry Trends, 2018-2028
3.4.1 Industry Trends - Ageing Population
3.4.2 Rising Prevalence of Chronic Diseases
3.4.3 Industry Trends – Personalised Healthcare
3.4.4 Industry Trends – National Regulations
3.4.5 Political Uncertainty and Security Risk across the World
3.4.6 Industry Trends – Economic Challenges
3.4.7 Industry Trends – Mergers and Acquisitions

4. Spinal Cord Stimulation Submarket, 2018-2028
4.1 Spinal Cord Stimulation (SCS) Market Overview, 2018
4.2 SCS Market Forecast: 2018-2028
4.3 Top Selling & Pipeline SCS Devices, 2018
4.4 Applications of Spinal Cord Stimulation
4.5 SCS Market Trends: 2018-2028

5. Deep Brain Stimulation Submarket, 2018-2028
5.1 Deep Brain Stimulation (DBS) Market Overview, 2018
5.2 DBS Market Forecast: 2018-2028
5.3 Top Selling & Pipeline DBS Devices, 2018
5.4 Applications of Deep Brain Stimulation
5.5 DBS Market Trends: 2018-2028

6. Gastric Electrical Stimulation Submarket, 2018-2028
6.1 Gastric Electrical Stimulation (GES) Market Overview, 2018
6.2 GES Market Forecast: 2018-2028
6.3 Top Selling GES Devices, 2018
6.4 Applications of Gastric Electrical Stimulation
6.5 GES Market Trends: 2018-2028

7. Vagus Nerve Stimulation Submarket, 2018-2028
7.1 Vagus Nerve Stimulation (VNS) Market Overview, 2018
7.2 VNS Market Forecast: 2018-2028
7.3 Top Selling & Pipeline VNS Devices, 2018
7.4 Applications of Vagus Nerve Stimulation
7.5 VNS Market Trends: 2018-2028

8. Sacral Nerve Stimulation Submarket, 2018-2028
8.1 Sacral Nerve Stimulation (SNS) Market Overview, 2018
8.2 SNS Market Forecast: 2018-2028
8.3 Top Selling & Pipeline SNS Devices, 2018
8.4 Applications of Sacral Nerve Stimulation
8.5 SNS Market Trends: 2018-2028

9. Other Neuromodulation Technologies Submarket, 2018-2028
9.1 Other Neuromodulation Technologies Overview, 2018
9.1.1 Trigeminal Nerve Stimulation
9.1.2 Cochlear Implants
9.1.3 Transcranial Magnetic Stimulation (TMS)
9.1.4 Transcranial Direct Current Stimulation (tDCS)
9.1.5 Ultrasonic Neuromodulation
9.2 Other Neuromodulation Techniques Forecast: 2018-2028

10. North American Neuromodulation Devices Market 2018-2028
10.1 Overview: North American Neuromodulation Devices Market 2018
10.2 The US Neuromodulation Devices Market: 2018-2028
10.2.1 The US Neuromodulation Devices Market Forecast: 2018-2028
10.3 The Canadian Neuromodulation Devices Market: 2018-2028
10.3.1 The Canadian Neuromodulation Devices Market Forecast: 2018-2028

11. Latin American Neuromodulation Devices Market 2018-2028
11.1 Overview: Latin American Neuromodulation Devices Market 2018
11.2 The Brazilian Neuromodulation Devices Market: 2018-2028
11.2.1 The Brazilian Neuromodulation Devices Market: Economic and Political Challenges Affecting Prospects
11.2.2 The Brazilian Neuromodulation Devices Market Forecast: 2018-2028
11.3 The Mexican Neuromodulation Devices Market: 2018-2028
11.3.1 The Mexican Neuromodulation Devices Market Forecast: 2018-2028
11.4 The rest of Latin America Neuromodulation Devices Market: 2018-2028
11.4.1 The rest of Latin America Neuromodulation Devices Market Forecast: 2018-2028

12. European Neuromodulation Devices Market 2018-2028
12.1 Overview: European Neuromodulation Devices Market 2018
12.2 The German Neuromodulation Devices Market: 2018-2028
12.2.1 The German Neuromodulation Devices Market Forecast: 2018-2028
12.3 The French Neuromodulation Devices Market: 2018-2028
12.3.1 The French Neuromodulation Devices Market – the Economy and its Implications
12.3.2 The French Neuromodulation Devices Market Forecast: 2018-2028
12.4 The UK Neuromodulation Devices Market: 2018-2028
12.4.1 The UK Neuromodulation Devices Market Forecast - Political Challenges
12.4.2 The UK Neuromodulation Devices Market Forecast: 2018-2028
12.5 The Italian Neuromodulation Devices Market: 2018-2028
12.5.1 The Italian Neuromodulation Devices Market Outlook
12.5.2 The Italian Neuromodulation Devices Market Forecast: 2018-2028
12.6 The Spanish Neuromodulation Devices Market: 2018-2028
12.6.1 The Spanish Neuromodulation Devices Market Forecast: 2018-2028
12.7 The Russian Neuromodulation Devices Market: 2018-2028
12.7.1 The Russian Neuromodulation Devices Market Forecast: 2018-2028
12.8 The rest of European Neuromodulation Devices Market: 2018-2028
12.8.1 The rest of European Neuromodulation Devices Market Forecast: 2018-2028

13. Asia-Pacific Neuromodulation Devices Market 2018-2028
13.1 Overview: Asia-Pacific Neuromodulation Devices Market 2018
13.2 The Japanese Neuromodulation Devices Market: 2018-2028
13.2.1 The Japanese Neuromodulation Devices Market –Regulation Effects
13.2.2 The Japanese Neuromodulation Devices Market Forecast: 2018-2028
13.3 The Chinese Neuromodulation Devices Market: 2018-2028
13.3.1 The Chinese Neuromodulation Devices Market – Amendments to Regulations
13.3.2 The Chinese Neuromodulation Devices Market Forecast: 2018-2028
13.4 The Indian Neuromodulation Devices Market: 2018-2028
13.4.1 The Indian Neuromodulation Devices Market Forecast: 2018-2028
13.5 The Australian Neuromodulation Devices Market: 2018-2028
13.5.1 The Australian Neuromodulation Devices Market Forecast: 2018-2028
13.6 The South-Korean Neuromodulation Devices Market: 2018-2028
13.6.1 The South-Korean Neuromodulation Devices Market Forecast: 2018-2028
13.7 The rest of Asia-Pacific Neuromodulation Devices Market: 2018-2028
13.7.1 The rest of Asia-Pacific Neuromodulation Devices Market Forecast: 2018-2028

14. Rest of the world Neuromodulation Devices Market 2018-2028
14.1 Overview: Rest of the world Neuromodulation Devices Market 2018
14.2 The Middle-Eastern Neuromodulation Devices Market: 2018-2028
14.2.1 The Middle-Eastern Neuromodulation Devices Market Forecast: 2018-2028
14.3 The African Neuromodulation Devices Market: 2018-2028
14.3.1 The African Neuromodulation Devices Market Forecast: 2018-2028

15. Neuromodulation Devices Market: Manufacturers
15.1 Medtronic
15.1.1 Sales and Recent Performance Analysis, 2017
15.1.2 Medtronic International Operations
15.1.3 Medtronic News
15.1.4 Medtronic Market Outlook
15.2 Boston Scientific Corporation
15.2.1 Sales and Recent Performance Analysis: 2017
15.2.2 Boston Scientific International Operations
15.2.3 Boston Scientific-Neuromodulation Performance
15.2.4 Boston Scientific News
15.2.5 Boston Scientific Market Outlook
15.3 St. Jude Medical (SJM) (now an Abbott company)
15.3.1 Sales and Recent Performance Analysis: 2016
15.3.2 Abbott International Operations, 2017
15.3.3 Abbot/ SJM News
15.3.4 SJM - Market Outlook
15.4 Cyberonics (now a LivaNova Company)
15.4.1 Sales and Recent Performance Analysis: 2017
15.4.2 LivaNova Company International Operations
15.4.3 Cyberonics News
15.4.4 Cyberonics (LivaNova) Market Outlook
15.5 Other Companies
15.5.1 Stryker Corporation
15.5.2 Nevro Corp.
15.5.2.1 Nevro Corp News.
15.5.3 SetPoint Medical
15.5.4 Functional Neuromodulation
15.5.5 Neurotherapies Reset
15.5.6 Wiringless Implantable Stretchable Electronics (WISE)
15.5.7 SceneRay
15.5.8 Mindray

16. Qualitative Analysis of the Neuromodulation Devices Market, 2017
16.1 SWOT Analysis of the Neuromodulation Devices Market
16.1.1 Strengths of the Market
16.1.2 Weaknesses
16.1.3 Opportunities in the Neuromodulation Devices Market
16.1.4 Threats Facing the Neuromodulation Devices Market
16.2 STEP Analysis of the Neuromodulation Devices Market
16.2.1 Social Factors: The Role of Neuroethics
16.2.2 Technological Developments: Drive towards Non-Invasive Methods
16.2.3 Economic Restraints: High Production Costs
16.2.4 Economic Potential: Emerging Markets Create Demand
16.2.5 Political Issues: Strong Government Influence
16.3 Snapshot of Companies in Active Clinical Trials
16.3.1 Neuromodulation Pipeline Products -2016-2018

17. Conclusions
17.1 The United States Retains its Position as Market Leader
17.2 Growing Incidences of Neurological Diseases
17.3 Ageing Population Drives Growth
17.4 China and India will lead the Emerging Markets
17.5 The Future of the Market - Deep Brain Stimulation and Vagus Nerve Stimulation
17.6 Concluding Remarks

Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain Report Evaluation Form

List of Tables
Table 3.1 Global Neuromodulation Devices Market by Type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 3.2 Global Neuromodulation Devices Market by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 4.1 SCS Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 4.2 Leading & Pipeline SCS Devices, 2018
Table 5.1 DBS Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 5.2 Leading & Pipeline DBS Devices, 2018
Table 6.1 GES Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 6.2 Leading GES Devices, 2018
Table 7.1 VNS Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 7.2 Leading VNS & Pipeline Devices, 2018
Table 8.1 SNS Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 8.2 Leading & Pipeline SNS Devices, 2018
Table 9.1 Leading & Pipeline Other Neuromodulation Devices, 2018
Table 9.2 Other Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 10.1 North American Neuromodulation Devices Market by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 10.2 North American Neuromodulation Devices Market by type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 10.3 The US Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 10.4 The Canadian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 11.1 Latin American Neuromodulation Devices Market by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 11.2 Latin American Neuromodulation Devices Market by Type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 11.3 The Brazilian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 11.4 The Mexican Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 11.5 The rest of Latin America Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 12.1 European Neuromodulation Devices Market by Country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 12.2 European Neuromodulation Devices Market by Type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 12.3 The German Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 12.4 The French Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 12.5 The UK Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 12.6 The Italian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 12.7 The Spanish Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 12.8 The Russian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 12.9 The rest of European Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 13.1 Asia-Pacific Neuromodulation Devices Market, by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 13.2 Asia-Pacific Neuromodulation Devices Market by Type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 13.3 The Japanese Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 13.4 The Chinese Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 13.5 The Indian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 13.6 The Australian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 13.7 The South-Korean Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 13.8 The rest of Asia-Pacific Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 14.1 Rest of the world Neuromodulation Devices Market by Country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 14.2 Rest of the world Neuromodulation Devices Market by Type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 14.3 The Middle-Eastern Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 14.4 The African Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
Table 16.1 Companies in Active Clinical Trials 2018-2028

List of Figures
Figure 1.1 Neuromodulation Devices Market Segmentation, 2018
Figure 3.1 Global Neuromodulation Devices Market by Type: Market Share (%) 2018
Figure 3.2 Global Neuromodulation Devices Market by Type: Market Share (%) 2028
Figure.3.3 Global Neuromodulation Devices Market by Country: Market Share (%) 2018
Figure 3.4 Global Neuromodulation Devices Market by Country: Market Share (%) 2028
Figure 3.5 Global Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 3.6 Global Neuromodulation Devices Market: Drivers and Restraints
Figure 4.1 SCS Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 5.1 DBS Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 6.1 GES Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 7.1 VNS Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 8.1 SNS Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 9.1 Other Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 10.1 North American Neuromodulation Devices Market by Country: Market Share (%) 2018
Figure 10.2 North American Neuromodulation Devices Market by Country: Market Share (%)2028
Figure 10.3 North American Neuromodulation Devices Market by Type: Market Share (%) 2018
Figure 10.4 North American Neuromodulation Devices Market by Type: Market Share (%)2028
Figure 10.5 North American Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 10.6 The US Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 10.7 The Canadian Neuromodulation Devices Market Revenue Forecast ($m) AGR (%), 2018-2028
Figure 11.1 Latin American Neuromodulation Devices Market by Country: Market Share (%) 2018
Figure 11.2 Latin American Neuromodulation Devices Market by Country: Market Share (%) 2028
Figure 11.3 Latin American Neuromodulation Devices Market by Type: Market Share (%) 2018
Figure 11.4 Latin American Neuromodulation Devices Market by Type: Market Share (%) 2028
Figure 11.5 Latin American Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 11.6 The Brazilian Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Fig 11.7 The Mexican Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 11.8 The rest of Latin America Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 12.1 European Neuromodulation Devices Market by Country: Market Share (%) 2018
Figure 12.2 European Neuromodulation Devices Market by Country: Market Share (%) 2028
Figure 12.3 European Neuromodulation Devices Market by Type: Market Share (%) 2018
Figure 12.4 European Neuromodulation Devices Market by Type: Market Share (%) 2028
Figure 12.5 European Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 12.6 The German Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 12.7 The French Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 12.8 The UK Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 12.9 The Italian Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 12.10 The Spanish Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 12.11 The Russian Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 12.12 The rest of European Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 13.1 Asia-Pacific Neuromodulation Devices Market by Country: Market Share (%) 2018
Figure 13.2 Asia-Pacific Neuromodulation Devices Market by Country: Market Share (%) 2028
Figure 13.3 Asia-Pacific Neuromodulation Devices Market by Type: Market Share (%) 2018
Figure 13.4 Asia-Pacific Neuromodulation Devices Market by Type: Market Share (%) 2028
Figure 13.5 Asia-Pacific Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 13.6 The Japanese Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure13.7 The Chinese Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 13.8 The Indian Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 13.9 The Australian Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 13.10 The South-Korean Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 13.11 The rest of Asia-Pacific Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 14.1 Rest of the world Neuromodulation Devices Market by Country: Market Share (%) 2018
Figure 14.2 Rest of the world Neuromodulation Devices Market by Country: Market Share (%) 2028
Figure 14.3 Rest of the world Neuromodulation Devices Market by Type: Market Share (%) 2018
Figure 14.4 Rest of the world Neuromodulation Devices Market, by type: Market Share (%)2028
Figure 14.5 Rest of the world Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 14.6 The Middle-Eastern Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 14.7 The African Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
Figure 15.1 Neuromodulation Devices Market: Market Share Analysis, 2016
Figure 15.2 Medtronic Revenue ($m), 2013-2017
Figure 15.3 Medtronic Operating Sectors (%), 2017
Figure 15.4 Medtronic Sales Shares (%), 2017
Figure 15.5 Boston Scientific Revenues ($m), 2013-2017
Figure 15.6 Boston Scientific Operating Sectors (%), 2017
Figure 15.7 Boston Scientific Sector Shares (%), 2017
Figure 15.8 Boston Scientific World Sales Shares (%), 2017
Figure 15.9 Boston Scientific Geographical Sales Shares (%), 2017
Figure 15.10 Boston Scientific Neuromodulation Historical Revenue ($m), 2015-2017
Figure 15.11 Boston Scientific Neuromodulation Revenue Shares (%) within Med-Surgical Sector, 2016
Figure 15.12 Abbott/ St. Jude Neuromodulation Revenues ($m), 2016
Figure 15.13 Abbott Operating Sectors (%) (2017)
Figure 15.14 Cardiovascular and Neuromodulation Operating Sectors (%), 2017
Figure 15.15 Abbott World Sales Shares (%), 2017
Figure 15.16 LivaNova Company Revenues ($m), 2015-2017
Figure 15.17 LivaNova Company Operating Sectors (%) (2017)
Figure 15.18 LivaNova World Sales for Neuromodulation Devices Shares (%), 2017
Figure 15.19 Nevro Corp. Revenue ($m), 2017
Figure 15.20 Nevro Corp World Sales for Neuromodulation Devices Shares (%), 2017
Figure 16.1 SWOT Analysis of the Neuromodulation Devices Market, 2017
Figure 16.2 STEP Analysis of the Neuromodulation Devices Market, 2017

Companies Listed

Abbott
Accellent
Advanced Uro-Solutions
Aleva Neurotherapeutics
Atrotech
Autonomic Technologies
Avery Biomedical
Axonics Modulation
Bard Electrophysiology
Bayer AG
BioControl Medical
Bioness, Inc.
BlueWind
Boston Scientific
CardioMEMS
Cerbomed GmbH
CerebralRx
CerebroMed
Cogentix Medical
Covidien
CVRx, Inc
Cyberonics
DBI
Deep Brain Innovations
electroCore
EndoNovo
EndoStim Inc
Enopace Biomedical
EnteroMedics
Functional Neuromodulation
Genesys Capital
Greatbatch
Halo Neuroscience
ImThera Medical
ImThera Medical, Inc.
InCube Labs
Integer Holdings Corporation
IoGyn, Inc.
Laborie Medical Technologies
Lake Region Medical
LivaNova
MagStim
MainStay Medical
Medtronic
Medtronic Eindhoven Design Centre (MEDC)
Medtronic International Trading Sarl
MedtronicNeuro
MetaCure
Metavention
Microtransponder
Mindray
Nanostim
NDI Medical
NeuImpulse
NeuroPace
NeuroSigma
NeuroStar
Neurotherapies Reset
NeuroTherm
NeuroVista Corp
NeuSpera
Nevro
Newronika
Nexstim plc
nUro Inc
Nuvectra Corporation
QiG Group,LLC
Rio Grande
Sapiens SBS
Sapiens Steering Brain Stimulation
SceneRay
Scion NeuroStim
SetPoint Medical
Sorin
SorinSpA
Soterix Medical
Spinal Modulation Inc
SPR Therapeutics
St. Jude Medical
StarMedTec
StimGuard, LLC.
Stimwave
Stryker Corporation
Synapse Medical
Urolplasty

List of Organisations Mentioned in the Report
Australia Institute of Health and Welfare
CFDA (the China Food and Drug Administration)
FDA
Foundation Medical Partners
Gaceta Médica de México
Health Canada
National Institute for Health and Care Excellence (NICE)
Nordic Neuromodulation Society
North American Neuromodulation Society (NANS)
Organization for Economic Cooperation and Development (OECD)
Pharmaceuticals and Medical Devices Agency (PMDA)
The University of Texas Health Science Center
University of Miami
World Health Organization (WHO)

You have successfully subscribed. Thank you.

An internal error has occurred. Please try again later.

close